VivoSeq
Other

Nanoparticle

0

Pipeline Programs↗

2

Active Trials↗

1

Companies Involved↗

Nanoparticle is an early-stage landscape with 0 programs across 1 company. The most active players are Gylden Pharma Ltd.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

80/100

Attrition Rate

14/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

G

Gylden Pharma Ltd

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

21

clinical trials

Completed12 · 57%
Unknown status4 · 19%
Terminated3 · 14%
Active, not recruiting2 · 10%

Clinical Trials

Trial Activity

21 trials

Dose Escalation Study of Immunomodulatory Nanoparticles
Active, not recruiting·RRadboud University Medical Center·Phase 1·NCT04751786·15 enrolled
Efficacy of Camel Whey Protein and Camel Whey Protein Nanoparticles for Treating Intra-bony Periodontal Defects
Active, not recruiting·KKafrelsheikh University·N/A·NCT07358104·44 enrolled
A Sunscreen Based on Bioadhesive Nanoparticles
Completed·YYale University·Phase 1·NCT02668536·13 enrolled
A New Clinical Use of Ferumoxytol Nanoparticles: An Antibiofilm Treatment
Completed·UUniversity of Pennsylvania·Phase 4·NCT06110494·44 enrolled
Evaluation of Antimicrobial Efficacy and Adaptability of Bioceramic Sealer Containing Nanoparticles
Completed·MMisr International University·Phase 4·NCT04481945·30 enrolled
The Anti-fungal Effect of Miconazol Versus Miconazol-Loaded Chitosan Nanoparticles
Completed·—·Phase 1·NCT06072716·80 enrolled
Clinical Efficacy of Novel Titanium Oxide Nanoparticle Enriched Bleaching Gel
Completed·PPakistan Institute of Medical Sciences·N/A·NCT06904118·60 enrolled
Clinical and Technical Feasibility of a Ultrasuperparamagnetic Nanoparticle Iron Oxide (USPIO)-Enhanced Magnetic Resonance Lymph Node Imaging
Completed·MM.D. Anderson Cancer Center·N/A·NCT01815333·10 enrolled
Clinical Assessment of Oxiconazole Nitrate Solid Lipid Nanoparticles Loaded Gel
Completed·MMinia University·Phase 1·NCT03823040·28 enrolled
The Effect of the Egg Shell Nanoparticles Combined With Titanium Dioxide Nanoparticles
Completed·EEgymedicalpedia·Phase 1·NCT06025084·24 enrolled
Modified Surface of PLGA Nanoparticles in Smart Hydrogel
Completed·—·Phase 1·NCT05442736·55 enrolled
Assessing a Natural Product Plus Bioadhesive Nanoparticle (BNP) Sunscreen
Completed·YYale University·Phase 1·NCT05736224·30 enrolled
A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against SARS-CoV-2
Completed·GGylden Pharma Ltd·Phase 1·NCT05113862·26 enrolled
A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against Dengue Virus
Completed·GGylden Pharma Ltd·Phase 1·NCT04935801·26 enrolled
Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI
Terminated·MM.D. Anderson Cancer Center·Phase 1·NCT01895829·7 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)